H. R. 1532—4 
‘‘(C) efficiently utilizing the Federal resources involved. 
‘‘(3) COMPREHENSIVE PLAN.— 
‘‘(A) IN GENERAL.—In carrying out paragraph (2), the 
Council shall make or update recommendations on the 
development, revision, and implementation of a comprehen-
sive plan to eliminate tuberculosis in the United States. 
‘‘(B) CONSULTATION.—In carrying out subparagraph 
(A), the Council may consult with appropriate public and 
private entities, which may, subject to the direction or 
discretion of the Secretary, include— 
‘‘(i) individuals who are scientists, physicians, 
laboratorians, and other health professionals, who are 
not officers or employees of the Federal Government 
and who represent the disciplines relevant to tuber-
culosis elimination; 
‘‘(ii) members of public-private partnerships or pri-
vate entities established to address the elimination 
of tuberculosis; 
‘‘(iii) members of national and international non-
governmental organizations whose purpose is to elimi-
nate tuberculosis; 
‘‘(iv) members from the general public who are 
knowledgeable with respect to tuberculosis elimination 
including individuals who have or have had tuber-
culosis; and 
‘‘(v) scientists, physicians, laboratorians, and other 
health professionals who reside in a foreign country 
with a substantial incidence or prevalence of tuber-
culosis, and who represent the specialties and dis-
ciplines relevant to the research under consideration. 
‘‘(C) CERTAIN COMPONENTS OF PLAN.—In carrying out 
subparagraph (A), the Council shall, subject to the direction 
or discretion of the Secretary— 
‘‘(i) consider recommendations for the involvement 
of the United States in continuing global and cross- 
border tuberculosis control activities in countries where 
a high incidence of tuberculosis directly affects the 
United States; and 
‘‘(ii) review the extent to which progress has been 
made toward eliminating tuberculosis. 
‘‘(4) BIENNIAL REPORT.— 
‘‘(A) IN GENERAL.—The Council shall submit a biennial 
report to the Secretary, as determined necessary by the 
Secretary, on the activities carried under this section. Each 
such report shall include the opinion of the Council on 
the extent to which its recommendations regarding the 
elimination of tuberculosis have been implemented, 
including with respect to— 
‘‘(i) activities under subsection (b); and 
‘‘(ii) the national plan referred to in paragraph 
(3). 
‘‘(B) PUBLIC.—The Secretary shall make a report sub-
mitted under subparagraph (A) public. 
‘‘(5) COMPOSITION.—The Council shall be composed of— 
‘‘(A) ex officio representatives from the Centers for 
Disease Control and Prevention, the National Institutes 
of Health, the United States Agency for International
H. R. 1532—5 
Development, the Agency for Healthcare Research and 
Quality, the Health Resources and Services Administration, 
the United States-Mexico Border Health Commission, and 
other Federal departments and agencies that carry out 
significant activities related to tuberculosis; 
‘‘(B) State and local tuberculosis control and public 
health officials; 
‘‘(C) 
individuals 
who 
are 
scientists, 
physicians, 
laboratorians, and other health professionals who represent 
disciplines relevant to tuberculosis elimination; and 
‘‘(D) members of national and international nongovern-
mental organizations established to address the elimination 
of tuberculosis.’’. 
(b) RULE
OF CONSTRUCTION REGARDING CURRENT MEMBER-
SHIP.—With respect to the advisory council under section 317E(f) 
of the Public Health Service Act, the amendments made by sub-
section (a) may not be construed as terminating the membership 
on such council of any individual serving as such a member as 
of the day before the date of the enactment of this Act. 
(c) FEDERAL TUBERCULOSIS TASK FORCE.—Section 317E of the 
Public Health Service Act (42 U.S.C. 247b–6) is amended— 
(1) by redesignating subsection (g) as subsection (h); and 
(2) by inserting after subsection (f) the following subsection: 
‘‘(g) FEDERAL TUBERCULOSIS TASK FORCE.— 
‘‘(1) DUTIES.—The Federal Tuberculosis Task Force (in this 
subsection referred to as the ‘Task Force’) shall provide to 
the Secretary and other appropriate Federal officials advice 
on research into new tools under subsection (b)(2), including 
advice regarding the efficient utilization of the Federal 
resources involved. 
‘‘(2) COMPREHENSIVE PLAN FOR NEW TOOLS DEVELOPMENT.— 
In carrying out paragraph (1), the Task Force shall make 
recommendations on the development of a comprehensive plan 
for the creation of new tools for the elimination of tuberculosis, 
including drugs, diagnostics, and vaccines. 
‘‘(3) CONSULTATION.—In developing the comprehensive plan 
under paragraph (1), the Task Force shall consult with external 
parties including representatives from groups such as— 
‘‘(A) scientists, physicians, laboratorians, and other 
health professionals who represent the specialties and dis-
ciplines relevant to the research under consideration; 
‘‘(B) members from public-private partnerships, private 
entities, or foundations (or both) engaged in activities rel-
evant to research under consideration; 
‘‘(C) members of national and international nongovern-
mental organizations established to address tuberculosis 
elimination; 
‘‘(D) members from the general public who are 
knowledgeable with respect to tuberculosis including 
individuals who have or have had tuberculosis; and 
‘‘(E) scientists, physicians, laboratorians, and other 
health professionals who reside in a foreign country with 
a substantial incidence or prevalence of tuberculosis, and 
who represent the specialties and disciplines relevant to 
the research under consideration.’’.
H. R. 1532—6 
Subtitle C—Evaluation of Public Health 
Authorities 
SEC. 121. EVALUATION OF PUBLIC HEALTH AUTHORITIES. 
(a) IN GENERAL.—Not later than 180 days after the date of 
enactment of the Comprehensive Tuberculosis Elimination Act of 
2008, the Secretary of Health and Human Services shall prepare 
and submit to the appropriate committees of Congress a report 
that evaluates and provides recommendations on changes needed 
to Federal and State public health authorities to address current 
disease containment challenges such as isolation and quarantine. 
(b) CONTENTS OF EVALUATION.—The report described in sub-
section (a) shall include— 
(1) an evaluation of the effectiveness of current policies 
to detain patients with active tuberculosis; 
(2) an evaluation of whether Federal laws should be 
strengthened to expressly address the movement of individuals 
with active tuberculosis; and 
(3) specific legislative recommendations for changes to Fed-
eral laws, if any. 
(c) UPDATE OF QUARANTINE REGULATIONS.—Not later than 240 
days after the date of enactment of this Act, the Secretary of 
Health and Human Services shall promulgate regulations to update 
the current interstate and foreign quarantine regulations found 
in parts 70 and 71 of title 42, Code of Federal Regulations. 
Subtitle D—Authorization of 
Appropriations 
SEC. 131. AUTHORIZATIONS OF APPROPRIATIONS. 
Section 317E of the Public Health Service Act, as amended 
by section 111(c) of this Act, is amended by striking subsection 
(h) and inserting the following: 
‘‘(h) AUTHORIZATION OF APPROPRIATIONS.— 
‘‘(1) GENERAL PROGRAM.— 
‘‘(A) IN
GENERAL.—For the purpose of carrying out 
this section, there are authorized to be appropriated 
$200,000,000 for fiscal year 2009, $210,000,000 for fiscal 
year 2010, $220,500,000 for fiscal year 2011, $231,525,000 
for fiscal year 2012, and $243,101,250 for fiscal year 2013. 
‘‘(B) RESERVATION
FOR
EMERGENCY
GRANTS.—Of the 
amounts appropriated under subparagraph (A) for a fiscal 
year, the Secretary may reserve not more than 25 percent 
for emergency grants under subsection (a) for any 
geographic area, State, political subdivision of a State, 
or other public entity in which there is, relative to other 
areas, a substantial number of cases of tuberculosis, 
multidrug resistant tuberculosis, or extensively drug resist-
ant tuberculosis or a substantial rate of increase in such 
cases. 
‘‘(C) PRIORITY.—In allocating amounts appropriated 
under subparagraph (A), the Secretary shall give priority 
to allocating such amounts for grants under subsection 
(a).
H. R. 1532—7 
‘‘(D) ALLOCATION OF FUNDS.— 
‘‘(i) REQUIREMENT OF FORMULA.—Of the amounts 
appropriated under subparagraph (A), not reserved 
under subparagraph (B), and allocated by the Secretary 
for grants under subsection (a), the Secretary shall 
distribute a portion of such amounts to grantees under 
subsection (a) on the basis of a formula. 
‘‘(ii) RELEVANT FACTORS.—The formula developed 
by the Secretary under clause (i) shall take into account 
the level of tuberculosis morbidity and case complexity 
in the respective geographic area and may consider 
other factors relevant to tuberculosis in such area. 
‘‘(iii) NO
CHANGE
TO
FORMULA
REQUIRED.—This 
subparagraph does not require the Secretary to modify 
the formula that was used by the Secretary to dis-
tribute funds to grantees under subsection (a) for fiscal 
year 2009. 
‘‘(2) LIMITATION.—The authorization of appropriations 
established in paragraph (1) for a fiscal year is effective only 
if the amount appropriated under such paragraph for such 
year equals or exceeds the amount appropriated to carry out 
this section for fiscal year 2009.’’. 
TITLE II—NATIONAL INSTITUTES OF 
HEALTH 
SEC. 201. RESEARCH AND DEVELOPMENT CONCERNING TUBER-
CULOSIS. 
Subpart 2 of part C of title IV of the Public Health Service 
Act (42 U.S.C. 285b et seq.) is amended by inserting after section 
424B the following section: 
‘‘SEC. 424C. TUBERCULOSIS. 
‘‘(a) IN GENERAL.—The Director of the National Institutes of 
Health may expand, intensify, and coordinate research and develop-
ment and related activities of the Institutes with respect to tuber-
culosis including activities toward the goal of eliminating such 
disease. 
‘‘(b) CERTAIN ACTIVITIES.—Activities under subsection (a) may 
include— 
‘‘(1) enhancing basic and clinical research on tuberculosis, 
including drug resistant tuberculosis; 
‘‘(2) expanding research on the relationship between such 
disease and the human immunodeficiency virus; and 
‘‘(3) developing new tools for the elimination of tuberculosis, 
including public health interventions and methods to enhance
H. R. 1532—8 
detection and response to outbreaks of tuberculosis, including 
multidrug resistant tuberculosis.’’. 
Speaker of the House of Representatives. 
Vice President of the United States and
President of the Senate.